Nedd4 and Itch are E3 ubiquitin ligases that ubiquitinate similar targets in vitro and thus are thought to function similarly. T cells lacking Itch show spontaneous activation and T helper type 2 polarization. To test whether loss of Nedd4 affects T cells in the same way, we generated Nedd4 +/+ and Nedd4 -/-fetal liver chimeras. Nedd4 -/-T cells developed normally but proliferated less, produced less interleukin 2 and provided inadequate help to B cells. Nedd4 -/-T cells contained more of the E3 ubiquitin ligase Cbl-b, and Nedd4 was required for polyubiquitination of Cbl-b induced by CD28 costimulation. Our data demonstrate that Nedd4 promotes the conversion of naive T cells into activated T cells. We propose that Nedd4 and Itch ubiquitinate distinct target proteins in vivo.
Nedd4 and Itch are E3 ubiquitin ligases that ubiquitinate similar targets in vitro and thus are thought to function similarly. T cells lacking Itch show spontaneous activation and T helper type 2 polarization. To test whether loss of Nedd4 affects T cells in the same way, we generated Nedd4 +/+ and Nedd4 -/-fetal liver chimeras. Nedd4 -/-T cells developed normally but proliferated less, produced less interleukin 2 and provided inadequate help to B cells. Nedd4 -/-T cells contained more of the E3 ubiquitin ligase Cbl-b, and Nedd4 was required for polyubiquitination of Cbl-b induced by CD28 costimulation. Our data demonstrate that Nedd4 promotes the conversion of naive T cells into activated T cells. We propose that Nedd4 and Itch ubiquitinate distinct target proteins in vivo.
The amount of protein present in a cell is determined by rates of production and degradation. Although the molecular mechanisms influencing protein production are relatively well understood, much less is known about how proteins are destroyed. However, it is known that the destructive process is initiated when ubiquitin is covalently attached to a target protein; accordingly, this process is regulated by the family of proteins known as 'ubiquitin ligases' 1, 2 .
Three groups of ubiquitin-processing enzymes have been identified. The E1 and E2 enzymes process ubiquitin, preparing it for transfer to protein substrates. The E3 ubiquitin ligases are responsible for selecting target proteins and directing the attachment of ubiquitin to these targets 2 . Of the E3 ubiquitin ligases, only members containing the domain homologous to the E6-AP carboxyl terminus (HECT domain) have intrinsic ubiquitin ligase activity; those of the RING domain family do not and therefore must remain associated with an E2 enzyme to function 2 . Both HECT-type and RING-type E3 ubiquitin ligases regulate protein degradation in T cells 3 .
Among the HECT-type E3 ubiquitin ligases, both Nedd4 (A001622) and Itch (A000959) are expressed in T cells [4] [5] [6] . Several lines of evidence suggest that Itch functions to maintain T cell tolerance. First, expression of Itch is higher when T cells are primed in the absence of costimulation with CD28 or the inducible costimulator ICOS 6, 7 . Second, mice with a genetic mutation that prevents Itch expression develop a severe inflammatory disease 8, 9 . Itch can promote the ubiquitination and subsequent destruction of several proteins that regulate T cell responsiveness in vitro, including Bcl-10, JunB, Cbl-b (A003923) and PKC-y 4, 6, 10, 11 . Notably, except for JunB, these targets can also be ubiquitinated by Nedd4, which suggests that Itch and Nedd4 might function similarly [12] [13] [14] . Here, however, we present data inconsistent with that hypothesis.
Because mice lacking Nedd4 die at birth, we generated fetal liver chimeras lacking Nedd4 only in hematopoietic cells. Unlike Itchdeficient T cells, T cells lacking Nedd4 proliferated poorly and were less likely to produce cytokines after stimulation. Also unlike Itchdeficient T cells, Nedd4-deficient T cells did not show spontaneous activation or excessive T helper type 2 (T H 2) polarization. The dissimilarities in the phenotypes of Itch-and Nedd4-deficient T cells suggest that Nedd4 and Itch ubiquitinate distinct targets. The T H 2-mediated disease in Itch mutant mice can be explained by the loss of Itch-mediated degradation of JunB, a transcription factor that promotes T H 2 polarization 4 . Here we found that defective activation of Nedd4-deficient T cells could be explained in part by impaired ubiquitination and degradation of Cbl-b, a protein that facilitates the destruction of signaling components of the T cell antigen receptor (TCR). On the basis of our data, we propose that Nedd4 ubiquitinates Cbl-b and promotes its destruction, thus allowing T cell activation to proceed.
RESULTS

Nedd4 -/-fetal liver chimeras
We used embryonic stem cells containing a gene-trapping vector inserted into intron 25 or 12 of Nedd4, which results in disruption of this gene 15 ( Supplementary Fig. 1a online) . The gene-trapping vector is composed of an artificial intron, a splice-acceptor site and a b-galactosidase-neomycin resistance cassette. Because Nedd4 -/-mice die at birth (data not shown), to study how the loss of Nedd4 affects T cell function, we generated fetal liver chimeras by transferring Nedd4 +/+ and Nedd4 -/-fetal liver cells into lethally irradiated C57BL/6 recipient mice. To confirm the genotyping, we analyzed Nedd4 protein from fetal liver chimera T cells by immunoblot ( Supplementary Fig. 1b ). Nedd4 +/+ and Nedd4 -/-fetal liver chimeras showed similar rates of death during the reconstitution process, which suggested that the number and viability of hematopoietic precursors in the fetal livers of Nedd4 +/+ and Nedd4 -/-embryos was similar.
T cells in mice lacking Itch undergo normal development but over time become spontaneously activated in vivo 4 . We sought to determine whether loss of Nedd4 similarly affected T cell development and activation. Nedd4 +/+ and Nedd4 -/-fetal liver chimeras showed no substantial difference in the number or percentage of thymocytes at each developmental stage or in the expression of TCRb protein on the thymocyte surface (Fig. 1a) . From these findings we inferred that Nedd4 is not required for T cell development.
In the lymph nodes and spleens of Nedd4 -/-fetal liver chimeras, the percentage of B cells and CD11b + cells was slightly lower, whereas the percentage of both CD4 + and CD8 + cells was higher (Fig. 1b,c) . In addition, we noted modestly but significantly larger numbers of T cells in spleens of Nedd4 -/-fetal liver chimeras (Fig. 1d) .
Impaired Nedd4 -/-effector T cell proliferation T cells from mice lacking Itch become activated as mice age and, as a consequence, have a surface phenotype characteristic of effector T cells (such as CD62L lo CD44 hi ) 4 . In contrast, relative to those from Nedd4 +/+ fetal liver chimeras, a higher percentage of splenic and lymph node CD4 + and CD8 + T cells from Nedd4 -/-fetal liver chimeras had a naive T cell surface phenotype (CD62L hi CD44 lo ; Fig. 2a,b) . These data indicate that loss of Nedd4 results in a defect in T cell activation.
When T cells are activated, their surface expression of CD69 and CD25 increases. Therefore, to test whether T cells lacking Nedd4 have a defect in initial activation, we measured expression of these activation markers on the surface of Nedd4 +/+ and Nedd4 -/-T cells. Nedd4 +/+ and Nedd4 -/-T cells showed similar upregulation of CD69 and CD25 (Fig. 2c) , which suggested that Nedd4 is not required for initial TCR-mediated activation events.
Having found that Nedd4 -/-mice had fewer effector T cells, we suspected that T cells lacking Nedd4 might respond poorly to antigen stimulation. To test our hypothesis, we immunized Nedd4 +/+ and Nedd4 -/-fetal liver chimeras with the I-A b -binding peptide 3K 16 and lipopolysaccharide (LPS) and assessed T cells specific for I-A b -3K at various time points. In lymph nodes draining the immunization site of Nedd4 +/+ mice, T cell populations specific for I-A b -3K had expanded from below the limit of detection to constitute approximately 0.41% of the total CD4 + T cell population (Fig. 3a) . In contrast, Nedd4-deficient T cell populations specific for I-A b -3K showed poor population expansion, accounting for only 0.23% of CD4 + T cells in the draining lymph nodes. This was not due to a delayed response by the Nedd4 -/-T cells specific for I-A b -3K, as both Nedd4 +/+ and Nedd4 -/-T cell populations specific for I-A b -3K contracted after day 9. Thus, T cells lacking Nedd4 proliferated poorly in response to antigen immunization.
Impaired Nedd4 -/-T cell help for B cells T cell proliferation is critical in the adaptive immune response, because T cell help for B cells is a limiting factor. T cells provide important signals that promote B cell proliferation, as well as antibody affinity maturation and class switching 17 . Thus, we next assessed whether the absence of Nedd4 in T cells prevented the T cells from delivering crucial signals to B cells. To analyze T cell help, we measured serum concentrations of immunoglobulins in unimmunized and immunized Nedd4 +/+ and Nedd4 -/-fetal liver chimeras. We immunized mice with ovalbumin (OVA) protein and complete Freund's adjuvant, then boosted the mice 3 weeks later with OVA and incomplete Freund's adjuvant. On day 4 after the second antigen dose (boost), we collected serum and measured the concentration of total and OVA-specific immunoglobulin. In the absence of immunization, Nedd4 -/-fetal liver chimeras had a higher concentration of immunoglobulin M (IgM), the non-class-switched version of immunoglobulin, and lower concentrations of all class-switched immunoglobulin isotypes analyzed (Fig. 3b) . We noted this same pattern for OVA-specific immunoglobulin that developed after immunization. These data collectively suggested that Nedd4 -/-T cells are not able to provide appropriate T cell help to B cells. However, it is also possible that B cells are intrinsically defective in the absence of Nedd4.
To determine whether Nedd4 is required for B cell function, we examined surface expression of the B cell antigen receptor, as well as of CD21 and CD23, all of which promote B cell activation. These receptors were expressed in similar amounts on Nedd4 +/+ and Nedd4 -/-B cells ( Supplementary Fig. 2a online) . We then examined B cell antigen receptor-induced upregulation of the activation markers CD69 and CD80; the latter facilitates the costimulation of T cells by binding to CD28 on the T cell surface. Neither CD69 expression nor CD80 expression was affected by the absence of Nedd4 (Supplementary Fig. 2b ). These data suggest that Nedd4 is not required for B cells to become activated, at least not the initial phases of B cell activation measured here.
Nedd4 -/-T cells produce less interleukin 2
We next assessed whether T cells lacking Nedd4 produced interleukin 2 (IL-2), a cytokine that promotes the proliferation of activated T cells. To do this, we isolated T cells from Nedd4 +/+ and Nedd4 -/-fetal liver chimeras and cultured these cells for 20 h in the presence or absence of plate-bound antibody to CD3 (anti-CD3) and anti-CD28, then measured IL-2 by intracellular cytokine staining. We chose this time point because it should allow examination of T cells at a time when they are producing IL-2 but have not yet undergone substantial proliferation. With this protocol, we found that in the absence of stimulation, neither Nedd4 +/+ nor Nedd4 -/-T cells contained detectable IL-2 ( Fig. 4a) . In contrast, after 20 h of activation, 38% of Nedd4 +/+ CD4 + T cells produced IL-2, whereas only 14% of T cells lacking Nedd4 contained measurable IL-2 ( Fig. 4a ). Comparing data from many experiments, we found significantly less IL-2 production by Nedd4 -/-T cells (Fig. 4b) . This difference could account for the poor proliferation of these cells.
We reasoned that if low IL-2 production by Nedd4 -/-T cells caused the diminished proliferation of these cells, adding exogenous IL-2 should restore proliferation. To test our hypothesis, we labeled Nedd4 -/-CD4 + T cells with the cytosolic dye CFSE (carboxyfluorescein diacetate succinimidyl diester), stimulated the cells in vitro and assessed their ability to proliferate in the absence or presence of additional IL-2 (10 U/ml). In the absence of added IL-2, activated Nedd4 -/-T cells underwent fewer divisions on average than did Nedd4 +/+ T cells (Fig. 4c) . However, when cells were cultured in the presence of exogenous IL-2, the proliferation of Nedd4 -/-T cells was similar to that of Nedd4 +/+ T cells. This finding suggests that lower IL-2 production accounted for the diminished proliferation of T cells lacking Nedd4. The lower IL-2 production by Nedd4 -/-T cells could have been due to a defect induced during development of the cells or, alternatively, the absence of Nedd4 from the cells at the time they were stimulated. To distinguish between those possibilities, we used small interfering RNA (siRNA) to decrease the expression of Nedd4 in D10 cells, a mature CD4 + T cell line, then analyzed the ability of these cells to make IL-2. We transfected D10 T cells with either control or Nedd4-specific siRNA and found that at 48 hours after transfection, Nedd4 protein expression was over 90% lower in cells transfected with Nedd4-specific siRNA than in mock-transfected cells (data not shown) or cells transfected with control siRNA (Fig. 4d) . T cells transfected with Nedd4 siRNA produced significantly less IL-2 than did cells transfected with control siRNA (Fig. 4d) . Thus, acute loss of Nedd4 in mature T cells is sufficient to decrease IL-2 production.
The data reported above collectively suggest that Nedd4 serves an important function in T cell activation by promoting or facilitating signals that stimulate proliferation and IL-2 production. Published data have shown that CD28 costimulation promotes both proliferation and IL-2 production 18, 19 . T cells from mice lacking CD28 respond to antigen similarly to T cells lacking Nedd4 (refs. 20-22) . Thus, we reasoned that Nedd4 might regulate a protein that inhibits CD28 signaling.
Nedd4 -/-T cells express excess Cbl-b
In vitro studies have shown that Nedd4 ubiquitinates many proteins 6, 10, 11, [23] [24] [25] . Such studies have often found that the same target proteins are ubiquitinated by Nedd4 and Itch 6, 10, 11 . However, these findings may reflect the in vitro 'promiscuity' of these E3 ubiquitin ligases rather than a true sharing of target protein specificity. Two lines of evidence support that hypothesis. First, neither of these E3 ubiquitin ligases is able to compensate for loss of the other in vivo 8 . Second, T cells lacking Itch are hyper-responsive, whereas those lacking Nedd4 are hyporesponsive.
Our data suggested that Nedd4 regulates a protein that inhibits T cell activation. Thus, to identify the mechanism by which Nedd4 regulates T cell function, we needed to focus on potential targets that would inhibit signals 'downstream' of T cell activation. PTEN and Cbl-b are two such candidates. PTEN dephosphorylates phosphatidylinositol-3,4,5-trisphosphate, thus opposing the effects of phosphatidylinositol-3-OH kinase and negatively regulating signals 'downstream' of CD28 costimulation [26] [27] [28] . Cbl-b is a RING-type ubiquitin ligase that is upregulated in a calcineurin-dependent way to promote T cell anergy 6 . Both PTEN and Cbl-b are ubiquitinated and degraded by Nedd4 in vitro 9, 24 . Thus, we sought to determine whether expression of either of these proteins was altered in Nedd4 -/-T cells.
As many proteins targeted for ubiquitination by members of the Nedd4 family are subsequently degraded 6, 10, 11, 24 , in the absence of Nedd4, target protein amounts would be expected to be higher in resting and/or activated T cells. We examined the expression of Nedd4 target proteins in T cell lines generated from Nedd4 +/+ and Nedd4 -/-mice. We cultured these T cell lines for 0-6 h or for 24 h alone or in the presence of ionomycin or a combination of phorbol 12-myristate 13-acetate (PMA) and ionomycin, then measured Cbl-b and PTEN proteins. In support of published data 6 , Cbl-b was expressed in Nedd4 +/+ T cells and its expression was higher in cells treated with the anergy-producing stimulus of ionomycin alone (Fig. 5) . In these same cells treated with PMA and ionomycin, Cbl-b protein expression remained low (Fig. 5) , again consistent with published data showing that CD28 signals promote the degradation of Cbl-b 29 .
Although T cells lacking Nedd4 had higher basal expression of Cbl-b, nonetheless, as in Nedd4 +/+ T cells, Cbl-b expression increased further after ionomycin treatment. However, unlike Nedd4 +/+ T cells, Nedd4 -/-T cells stimulated with PMA and ionomycin showed an initial decrease followed by a sustained increase in Cbl-b expression (Fig. 5) . Cbl-b increased in Nedd4 -/-T cells from 3 h to 24 h after stimulation, which suggested that Cbl-b was not being appropriately degraded. Normalization of protein amounts at 24 h showed that when activated with both PMA and ionomycin, Nedd4 -/-T cells had significantly more Cbl-b than did Nedd4 +/+ T cells (Fig. 5c) . These data collectively support the idea that Nedd4 is involved in the ubiquitination and degradation of Cbl-b after T cell stimulation. However, on the basis of these data, we could not rule out the possibility that a defect in Nedd4 -/-T cell signaling alters Cbl-b transcription rather than ubiquitin-mediated degradation. This might occur if these cells contained more PTEN.
T cells with more PTEN would be less able to propagate signals 'downstream' of the CD28 costimulatory receptor. We postulated that if Nedd4 regulates the ubiquitination and degradation of PTEN in T cells, then Nedd4 -/-T cells might have more PTEN quantities and, thus, less signaling. To address that possibility, we measured the relative expression of PTEN protein.
We were unable to detect any difference in PTEN protein expression in Nedd4 +/+ versus Nedd4 -/-T cells regardless of the timing or type of stimulation (Fig. 5) . These data suggest that Nedd4 does not regulate PTEN protein expression in T cells in these conditions. However, these data do not show whether Nedd4 regulates Cbl-b by affecting transcription or ubiquitin-mediated degradation.
Nedd4 is an E3 ubiquitin ligase, so the most likely possibility was that Nedd4 affects the turnover of Cbl-b protein. To test that idea, we blocked protein production with cycloheximide, a potent inhibitor of translation ( Supplementary Fig. 3a online) . Between 6 h and 10 h after activation, Cbl-b degradation was evident in Nedd4 +/+ but not Nedd4 -/-T cells (Supplementary Fig. 3b ). The results of several such experiments showed that very little Cbl-b degradation occurred in resting T cells regardless of whether or not they contained Nedd4. After 5 h of activation, however, there was considerable turnover of Cbl-b in cells containing Nedd4 but not in those lacking Nedd4 ( Supplementary  Fig. 3c ). Thus, Nedd4 promotes Cbl-b degradation and this may account for the difference in the amount of Cbl-b in activated Nedd4 +/+ versus Nedd4 -/-T cells.
Nedd4 binds and ubiquitinates Cbl-b
The generation of T cell lines requires one or more round(s) of stimulation and propagation in the presence of IL-2. It is possible that the results described above were artifacts of cell lines and did not reflect the situation that would occur in primary T cells. To rule out that possibility, we measured Cbl-b protein expression in primary T cells isolated from Nedd4 +/+ and Nedd4 -/-fetal liver chimeras (Fig. 6a) . Consistent with the data obtained with T cell lines, Cbl-b expression was higher in the Nedd4 -/-T cells stimulated with anti-CD3 and anti-CD28. As an added precaution, we tested the antibody to Cbl-b used in these experiments and found that it was specific for Cbl-b ( Supplementary  Fig. 4 online) . Thus, Cbl-b was not ubiquitinated or degraded in primary T cells lacking Nedd4.
We next sought to ascertain whether Nedd4 was required for the ubiquitination of Cbl-b. We immunoprecipitated Cbl-b from primary Nedd4 +/+ and Nedd4 -/-T cells and did immunoblot analysis for ubiquitin (Fig. 6b) . We noted much less polyubiquitination of Cbl-b immunoprecipitated from Nedd4 -/-T cells stimulated with anti-CD3 and anti-CD28 than from their stimulated Nedd4 +/+ counterparts. These data support the idea that Nedd4 is involved in the ubiquitination of Cbl-b and suggest that Nedd4 might be particularly relevant in the degradation of Cbl-b that occurs as a consequence of T cell activation. On the basis of that, we predicted that Nedd4 interacts with Cbl-b in activated T cells. Thus, we immunoprecipitated Nedd4 from Nedd4 +/+ and Nedd4 -/-T cells left unstimulated or stimulated for 16 h with anti-CD3 and anti-CD28 (Fig. 6c) . As expected, we were able to immunoprecipitate Nedd4 from Nedd4 +/+ 
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Nedd4 but not Nedd4 -/-T cells. Additionally, we found that Cbl-b immunoprecipitated together with Nedd4 in stimulated but not unstimulated Nedd4 +/+ T cells. These data collectively suggest that when wild-type T cells are stimulated, Nedd4 binds to and ubiquitinates, and thus promotes the degradation of, Cbl-b. Furthermore, our data suggest that the degradation of Cbl-b may be necessary for T cells to become fully activated, make IL-2 and proliferate to their full capacity.
If our hypothesis is correct, then the decrease in IL-2 caused by loss of Nedd4 should not occur if Cbl-b is simultaneously decreased. To test that, we transfected activated primary CD4 + T cells with siRNA specific for Nedd4 or Cbl-b, alone and in combination. As a control, we used a pool of siRNAs that deplete irrelevant proteins. Protein expression measured 48 h and 72 h after transfection showed that Nedd4 was decreased approximately 90% by the Nedd4-specific siRNA, whereas Cbl-b was decreased 40% by the Cbl-b-specific siRNA, relative to protein amounts resulting from transfection of control siRNA (Fig. 7) . We tested several different Cbl-b-specific siRNAs alone or in combination and found that the decrease of 40% was the best we could achieve. Nevertheless, this decrease seemed to be effective, as IL-2 production increased when we transfected T cells with Cbl-b-specific siRNA (data not shown). As expected, Nedd4-specific siRNA significantly decreased T cell IL-2 production; however, this production was restored by simultaneous transfection with Cbl-b-specific siRNA (Fig. 7) . Our data collectively indicate that Nedd4 promotes the degradation of Cbl-b and thus regulates a checkpoint in T cell activation that 'authorizes' IL-2 production and subsequent proliferation after TCR and CD28 stimulation.
DISCUSSION
By studying mice lacking Nedd4 in hematopoietic cells, we have made several notable observations. First, by all measures analyzed in this study, Nedd4 -/-fetal liver chimeras had a phenotype very different from that of mice lacking Itch. Mice lacking Itch have hyperresponsive T cells 8 , whereas mice lacking Nedd4 (in the hematopoietic compartment) had hyporesponsive T cells. One interpretation of this observation is that these two E3 ubiquitin ligases act on similar targets but in an opposite way. That hypothesis seems unlikely, given that both of these E3 ligases seem to lead to similar outcomes, polyubiquitination and degradation, when tested on a given target protein in vitro 6,9,10 . Additionally, both of these E3 ubiquitin ligases catalyze the production of lysine 48-linked polyubiquitin chains when tested on a synthetic substrate 30 . Such data suggest that Nedd4 and Itch do not oppose each other by ubiquitinating the same target proteins in a functionally distinct way. A more likely scenario is that Nedd4 and Itch, although structurally similar, ubiquitinate different target proteins in vivo. This hypothesis presumes that in vitro ubiquitination assays and overexpression systems promote 'promiscuous' activity by these E3 ubiquitin ligases and thus, although useful for studying ligase activity, these assays do not allow an accurate prediction of whether the E3 ubiquitin ligase interacts with a given target in vivo.
Nedd4 can ubiquitinate more than a dozen potential target proteins in vitro 6, 10, 11, 23, 25, [31] [32] [33] [34] . At least eight of these proteins are also ubiquitinated in vitro by Itch 6, 10, 11, 35 . Targets that might be relevant to Nedd4 function in T cells include Notch1, PKC-y, phospholipase C-g1, PTEN, Cbl-b, c-Cbl and Bcl- 10 (refs. 26,36-43) . Among those, PTEN and Cbl-b stand out as potent inhibitors of T cell activation. Of those two proteins, Cbl-b can be ubiquitinated by both Nedd4 and Itch 9 , whereas ubiquitination of PTEN by Itch has not been reported. Although PTEN was not more abundant in Nedd4 -/-T cells, Cbl-b expression was much higher in Nedd4 -/-T cells than in Nedd4 +/+ control cells. Unlike Nedd4 +/+ control cells, Nedd4 -/-T cells stimulated with both PMA and ionomycin had higher expression of Cbl-b, which suggests that Cbl-b is degraded after T cells are activated. These findings suggest that Nedd4 functions only in certain circumstances. Notably, Nedd4 protein expression did not change much after stimulation. Thus, it seems possible that Nedd4 relies on an adaptor protein that is expressed only in activated T cells.
Whereas Cbl-b degradation was evident only in activated T cells, Cbl-b was ubiquitinated in both stimulated and unstimulated Nedd4 -/-T cells. That finding suggests that Cbl-b polyubiquitination in unstimulated T cells is nondegradative. A thorough analysis of Cbl-b ubiquitination in both activated and naive T cells will help to resolve this issue. It will also be useful to determine how Cbl-b is ubiquitinated in unstimulated T cells and whether the switch from nondegradative to degradative forms of ubiquitination involves a deubiquitinating enzyme.
Whereas the absence of Cbl-b leads to hyper-responsive T cells, more Cbl-b is coincident with T cell anergy. That suggests that large quantities of Cbl-b could inhibit T cell activation and cause the hyporesponsiveness of Nedd4 -/-T cells. We confirmed that hypothesis by simultaneously depleting cells of both Nedd4 and Cbl-b; less Cbl-b in T cells lacking Nedd4 restored IL-2 production. Whether impaired Cbl-b degradation causes all the defects in Nedd4 -/-T cells is not certain; nevertheless, the fact remains that Nedd4 expression is required for T cells to become fully activated.
Notably, Nedd4 -/-fetal liver chimeras had more CD4 + T cells and CD8 + T cells. This could have been due to abnormal development of T cell progenitors or to altered T cell homeostasis. The latter option seems unlikely, as these cells did not have a CD44 hi CD62L lo phenotype. Future studies will need to focus on whether these higher T cell numbers are due to altered amounts of Cbl-b or, alternatively, whether this is due to another Nedd4-regulated pathway.
METHODS
Generation of Nedd4 -/-fetal liver chimeras. Targeted embryonic stem cell lines with disruption of mouse Nedd4 by means of a gene-trapping vector inserted into intron 25 or 12 (XA209 or XB398, respectively; BayGenomics) were injected into mouse blastocysts for the generation of chimeras as described 5, 44, 45 . Fetal liver cell suspensions from Nedd4 +/+ and Nedd4 -/-embryos at days 14-16 were transferred by injection into tail veins of lethally irradiated 6-to 10-week-old C57BL/6 recipients that had received a 'split dose' of 800 rads, followed by 2 h of rest, then 400 rads.
Mice. C57BL/6J mice were from The Jackson Laboratory. Unless otherwise specified, mice used in experiments were 8-10 weeks old. All mice were maintained in a specific pathogen-free barrier facility. Care of mice used met the standards set forth by the National Institutes of Health in their guidelines for the care and use of experimental animals.
T cell isolation and stimulation and production of T cell lines. T cells were isolated from lymph nodes and/or spleens with nylon wool. T cell lines were generated as described 5 . For short-term in vitro stimulation, cells were cultured in the absence of IL-2 on plates coated with anti-CD3 (50 mg/ml; 145-2C11) and anti-CD28 (37.51; both purified 'in house') or with ionomycin (1 mM; Calbiochem) with or without PMA (50 ng/ml; Calbiochem). Immunization and analysis of serum immunoglobulin isotypes. For analysis of T cell expansion in vivo, mice were immunized subcutaneously in the hind leg with 10 mg 3K and 7 mg LPS. Draining lymph node cells were collected and were stained with I-Ab-3K tetramer as described 16 . Data were acquired on a CYAN flow cytometer (Cytomation) and analyzed by FlowJo software (Tree Star). For measurement of serum immunoglobulin, mice were immunized subcutaneously with 100 mg OVA and 7 mg complete Freund's adjuvant emulsion and then boosted with OVA and incomplete Freund's adjuvant as described 5 . Total or OVA-specific immunoglobulin was measured by enzymelinked immunosorbent assay (ELISA) as described 5 .
Antibodies. For surface staining, cells were incubated with antibodies diluted in supernatant conditioned by the antibody 2.4G2 (to block Fcg receptors; prepared 'in house'). Antibodies used for flow cytometry were from BD Biosciences except anti-TCRb (Ham597; prepared 'in house') 46 . Antibodies used for immunoblot analysis were as follows: anti-Nedd4 (07-049 (Upstate) and 611480 (BD Transduction Labs)), antibody to glyceraldehyde phosphate dehydrogenase (GAPDH; MAB374; Chemicon International), anti-Cbl-b (G-1; Santa Cruz Biotechnology), anti-ubiquitin (P4D1; Cell Signaling Technology) and anti-PTEN (9552; Cell Signaling Technology). Secondary antibodies were goat anti-mouse IgG1 (A680; Molecular Probes) and goat anti-rabbit IgG conjugated to IRDye (800CW; Li-Cor Biosciences).
Assay with siRNA. CD4 + T cells were stimulated with anti-CD3 and anti-CD28 as described above and their populations were expanded for 2-4 d in IL-2. Approximately 5 Â 10 6 cells were transfected by electroporation with 400 pmol siRNA (mouse Nedd4 siGenome On-Target plus Smart Pool L-058562-00-0010; mouse Cbl-b siGenome On-Target plus Smart Pool L-051830-00-0010; mouse control siGenome On-Target plus Smart Pool; Dharmacon RNA Technologies) with a BTX ECM 830 Squarewave Electroporator, followed by culture for 48 h in the presence of IL-2. Cells that had undergone electroporation were restimulated for 24 h without exogenous IL-2 and IL-2 was measured with the Mouse IL-2 ELISA Ready-SET-Go! reagent set (eBioscience).
Cycloheximide treatment, immunoprecipitation and immunoblot analysis. After the stimulation period specified in Supplementary Figure 3b , cells were incubated for 4 h with Cycloheximide Ready-Made solution (30 mg/ml; Sigma) and then lysed as described 5 for immunoblot analysis. After lysis, proteins were quantified with a Micro BCA kit (Pierce Protein Research) and 10-20 mg whole-cell lysates were used per lane. Alternatively, 1 Â 10 6 cells were lysed in 40 ml sample buffer, sonicated briefly and heated to 100 1C before being loading. For immunoprecipitation, lysates were precleared with protein A/G Sepharose beads (Pierce), followed by immunoprecipitation for 1 h at 4 1C with antiNedd4 or anti-Cbl-b and protein A/G Sepharose beads. Eluted proteins were separated by SDS-PAGE and transferred to Immobilon-FL membranes (Bio-Rad). Membranes were blocked with Li-Cor blocking buffer, then were analyzed by immunoblot and imaged with the Odyssey system (Li-Cor Biosciences).
